Minnesota medtech accelerator debuts, with Medtronic vet at the helm

An executive with R&D experience from Medtronic ($MDT) is co-launching Inceptis, a new medtech accelerator based in Minnesota. Daniel Sigg served as senior research manager at Medtronic a few years back and has also served in executive roles at various life sciences companies, according to his LinkedIn profile. Devicix, a product development and engineering firm, is also an equal partner in the enterprise, MedCity News reports. Inceptis will focus on Class II medical devices and plans to begin raising between $10 million and $14 million in the fall, according to the article. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.